Lovoi & Sons Pharmacies Inc Beaumont, TX - 77701

Lovoi & Sons Pharmacies Inc is categorized under Real Estate Management in Beaumont, TX and active since 1968.

Lovoi & Sons Pharmacies Inc was established in 1968, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Real Estate Management business, which does work in the B2B market, and is classified as a Real Estate Management, under code number 4461100 by the NAICS.

If you are seeking more information, feel free to contact J Lovoi, Owner at the company’s single location by writing to 3480 Fannin St, Beaumont, Texas TX 77701 or by phoning (409) 833-7538. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Lovoi & Sons Pharmacies Inc
Contact Person: J Lovoi, Owner
Address: 3480 Fannin St, Beaumont, Texas 77701
Phone Number: (409) 833-7538
Website Address: lovoiandsons.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 1968
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Real Estate Management
SIC Code: 6531
NAICS Code: 4461100
Share This Business:

Lovoi & Sons Pharmacies Inc was started in 1968 to provide professional Real Estate Management under the SIC code 6531 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact J Lovoi, Owner for inquiries that concern Lovoi & Sons Pharmacies Inc by calling the company number (409) 833-7538, as your correspondence is most welcome. Additionally, the physical location of the single location of Lovoi & Sons Pharmacies Inc can be found at the coordinates 30.07202,-94.12729 as well as the street address 3480 Fannin St in Beaumont, Texas 77701.

For its online presence, you may visit Lovoi & Sons Pharmacies Inc’s website at lovoiandsons.com and engage with its social media outlets through on Twitter and on Facebook.